BCO
The Brink's Company
BCO has a slight edge over RKLB overall, supported by lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BCO's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $117 | — |
| Cheap | 22x | $84.90 | -27% |
| Fair | 31x | $117 | +0.3% |
| Current | 31x | $117 | — |
| Expensive | 91x | $346 | +196% |
Historical ranges are pointers, not guarantees.
BCO's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
BCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BCO's earnings to grow and its profitability to improve, with its revenue holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over BCO on the outlook, with more favorable revenue expectations.
BCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.35 | +145% |
| Q3 2026 | $3.81 | -3.3% |
| Q2 2026 | $4.32 | +16% |
| Q1 2026 | $4.28 | +15% |
| Q4 2025 | $4.69 | +29% |
| Q3 2025 | $3.94 | +48% |
| Q2 2025 | $3.73 | +25% |
| Q1 2025 | $3.72 | +41% |
| Q4 2024 | $3.63 | +94% |
BCO has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
BCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +3% |
| Q2 2026 | $1.4B | +7.1% |
| Q1 2026 | $1.4B | +10% |
| Q4 2025 | $1.4B | +9.1% |
| Q3 2025 | $1.3B | +6.1% |
| Q2 2025 | $1.3B | +3.8% |
| Q1 2025 | $1.2B | +0.9% |
| Q4 2024 | $1.3B | +1.5% |
BCO's revenue has grown year over year every quarter since late 2020: $1.4B last quarter, up 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.5% | -1.9 points |
| Q2 2026 | 9.6% | -0.7 points |
| Q1 2026 | 8% | -1.5 points |
| Q4 2025 | 13% | +4.8 points |
| Q3 2025 | 11% | +2.6 points |
| Q2 2025 | 10% | +1 points |
| Q1 2025 | 9.6% | -0.2 points |
| Q4 2024 | 8.3% | +0.1 points |
BCO has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over BCO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
BCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.4M | -32% |
| Q2 2026 | $1.7M | -99% |
| Q1 2026 | -$11.4M | +$107.7M |
| Q4 2025 | $325.9M | +6.1% |
| Q3 2025 | $77.4M | +946% |
| Q2 2025 | $152.2M | +$275M |
| Q1 2025 | -$119.1M | -1118% |
| Q4 2024 | $307.2M | -9.6% |
BCO has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
BCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Moderate |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 2.8x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.4x | Elevated |
BCO's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.0 | Neutral |
| Stochastic | 53.4 | Neutral |
BCO's weekly RSI is 57 (neutral) and its Stochastic is 53 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
BCO PE vs Industrials Sector
| Metric | BCO | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 28% above |
| PE % | 49 | 58 | 9 pts below |
BCO is trading at 31x earnings, a 28% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
BCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.3 | 9.1% above |
| 20 week MA | $110.0 | 6.3% above |
| 50 week MA | $111.7 | 4.7% above |
| 100 week MA | $104.4 | 12% above |
| 200 week MA | $94.0 | 24% above |
BCO has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
BCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $91.1 | $70.8 | -22% |
| 2021 | $70.8 | $64.7 | -8.6% |
| 2022 | $64.7 | $54.1 | -16% |
| 2023 | $54.1 | $88.0 | +63% |
| 2024 | $88.0 | $91.7 | +4.3% |
| 2025 | $91.7 | $119.6 | +30% |
| 2026 YTD | $119.6 | $117.0 | -2.2% |
BCO has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.